Research Article
Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes
Table 2
Changes of immune cells among total 35 patients during follow-up.
| Immune cells | 0 month | 6 months | value |
| Treg | | | <0.001 | Th17 | | | <0.001 | Th17/Treg | | | <0.001 | Tfh | | | <0.001 | Th1 | 0.30 (0.13-1.27) | 0.18 (0.03-0.25) | 0.003 | Th2 | 0.38 (0.09-0.87) | 0.29 (0.14-0.89) | 0.71 | Th1/Th2 | 1.55 (0.44-5.33) | 0.28 (0.10-1.38) | <0.001 | Breg | | | <0.001 | CD3 | | | 0.010 | CD4 | | | <0.001 | CD8 | | | 0.27 | CD4/CD8 | | | 0.48 |
|
|
|